According to an article by Medscape, regular use of aspirin may result in a 50% reduction in emphysema progression in elderly COPD patients.
Results of the study included:
- Progression of percent emphysema was slower among regular aspirin users compared to non-aspirin users
- Results were similar in ever-smokers and for doses of 81 mg and 300-325 mg. A greater magnitude effect was seen among participants with airflow limitations.
- No association was found between aspirin use and change in lung function.